Stock RGEN REPLIGEN CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Company Repligen Corporation

Equities

RGEN

US7599161095

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
167.9 USD -2.00% Intraday chart for Repligen Corporation +4.27% -6.64%
Apr. 08 RBC Cuts Price Target on Repligen to $221 From $225, Keeps Outperform Rating MT
Mar. 20 Transcript : Repligen Corporation Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-20-2024 03:00 PM

Business Summary

Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. The Company's bioprocessing business consists of four main franchises: filtration (including fluid management); chromatography; process analytics, and proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. The Company’s chromatography franchise includes a number of products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. The Company’s TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes.

Sales per Business

USD in Million2022Weight2023Weight Delta
Filtration
54.4 %
496 61.9 % 348 54.4 % -29.87%
Chromatography
19.8 %
132 16.4 % 127 19.8 % -3.84%
Proteins
16.2 %
114 14.3 % 103 16.2 % -9.50%
Process Analytics
8.9 %
54 6.7 % 57 8.9 % +6.18%
Other Product
0.6 %
6 0.7 % 4 0.6 % -35.76%
Royalty and Other
0.1 %
0 0.0 % 0 0.1 % +8.50%

Sales per region

USD in Million2022Weight2023Weight Delta
North America
44.0 %
345 43.0 % 281 44.0 % -18.45%
Europe
37.0 %
297 37.0 % 236 37.0 % -20.31%
APAC
19.0 %
160 20.0 % 121 19.0 % -24.29%

Managers

Managers TitleAgeSince
Tony Hunt CEO
 Chief Executive Officer 60 14-04-30
Olivier Loeillot PSD
 President 54 23-10-01
Jason Garland DFI
 Director of Finance/CFO 50 23-09-24
James Bylund COO
 Chief Operating Officer 61 20-02-29
Ralf Kuriyel CTO
 Chief Tech/Sci/R&D Officer 66 16-10-17
Sondra S. Newman IRC
 Investor Relations Contact - -
Jaime Humara SAM
 Sales & Marketing - 22-10-31
Kola Otitoju PRN
 Corporate Officer/Principal - -
Christine Gebski PRN
 Corporate Officer/Principal 56 14-12-31
Vikas Gupta PRN
 Corporate Officer/Principal - 16-02-29

Members of the board

Members of the board TitleAgeSince
Karen Dawes CHM
 Chairman 72 05-08-31
Nicolas Barthelemy BRD
 Director/Board Member 58 14-06-11
Martin Madaus BRD
 Director/Board Member 64 23-02-05
Glenn Muir BRD
 Director/Board Member 65 15-09-30
Carrie Manner BRD
 Director/Board Member 50 20-06-10
Tony Hunt CEO
 Chief Executive Officer 60 14-04-30
Konstantin Konstantinov BRD
 Director/Board Member 66 22-05-25
Rohin Mhatre BRD
 Director/Board Member 59 20-02-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 55,838,548 52,159,662 ( 93.41 %) 0 93.41 %

Shareholders

NameEquities%Valuation
BlackRock Advisors LLC
12.65 %
7,053,434 12.65 % 1 297 M $
Vanguard Fiduciary Trust Co.
9.106 %
5,078,294 9.106 % 934 M $
T. Rowe Price International Ltd.
7.191 %
4,010,255 7.191 % 738 M $
Estate Of Roy T Eddleman
6.276 %
3,500,000 6.276 % 644 M $
Fidelity Management & Research Co. LLC
3.375 %
1,882,516 3.375 % 346 M $
STATE STREET CORPORATION
3.055 %
1,703,618 3.055 % 313 M $
Macquarie Investment Management Business Trust
2.813 %
1,568,792 2.813 % 289 M $
Brown Capital Management LLC
2.735 %
1,525,064 2.735 % 280 M $
Artisan Partners Holdings LP
2.730 %
1,522,743 2.730 % 280 M $
Sands Capital Management LLC
2.681 %
1,495,337 2.681 % 275 M $

Company contact information

Repligen Corp.

41 Seyon Street Building 1, Suite 100

02453, Waltham

+781 250 0111

http://www.repligen.com
address Repligen Corporation(RGEN)

Group companies

NameCategory and Sector
Repligen Europe BV
Logo Repligen Europe BV

Repligen Europe BV

Medical DistributorsDistribution Services

Part of Repligen Corp., Repligen Europe BV is a Dutch company that wholesales medical and dental instruments. The private company is located in Netherlands.

Medical Distributors

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Medical Equipment, Supplies & Distribution
Other Medical Equipment, Supplies & Distribution

Sales per Business

Sales per region

Ratings for Repligen Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
167.9 USD
Average target price
210.9 USD
Spread / Average Target
+25.63%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
REPLIGEN CORPORATION Stock Repligen Corporation
-6.64% 9.37B
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.89% 185B
MEDTRONIC PLC Stock Medtronic plc
-2.43% 107B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.10% 67.55B
DEXCOM, INC. Stock DexCom, Inc.
+11.10% 54.6B
CENCORA, INC. Stock Cencora, Inc.
+15.86% 47.42B
HOYA CORPORATION Stock Hoya Corporation
+3.86% 42.24B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+9.55% 28.24B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+1.85% 26.42B
TERUMO CORPORATION Stock Terumo Corporation
+12.40% 25.66B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. RGEN Stock
  4. Company Repligen Corporation